Wyeth, Schwarz Off Hook In Generic Reglan Suit

By Christine Caulfield

Law360, New York (November 16, 2009, 5:20 PM ET) -- Wyeth Inc. and Schwarz Pharma Inc. have prevailed again in a lawsuit that alleged the brand-name pharmaceutical companies should have warned consumers that a copycat version of their anti-heartburn medicine Reglan could cause an incurable neurological disorder.

The ruling, issued by Judge John Copenhaver Jr. in the U.S. District Court for the Southern District of West Virginia on Friday, granted the drug makers their bid for summary judgment after they had argued that they weren't responsible for the harmful side effects of generic versions of Reglan....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles